US Pharma MarketingTyra creates awareness day with patient advocates to shine light on a rare cancer
Tyra Biosciences has Tyra Biosciences has partnered with a patient advocacy group to create an awareness day for upper tract urothelial cancer, a rare tumor type its lead drug candidate targets.
Tyra Biosciences has partnered with a patient advocacy group to create an awareness day for upper tract urothelial cancer, a rare tumor type its lead drug candidate targets.
Source: FiercePharma